Key result
Atypical antipsychotics showed a wide range of D2 receptor occupancy at clinically effective doses, suggesting clinical response may be maintained with D2 receptor occupancy below 65%.
Why the study?
What is the relationship between plasma concentration and D2 receptor occupancy over time for atypical antipsychotics in stabilized schizophrenic patients?
Observational (n=46)
What is the relationship between plasma concentration and D2 receptor occupancy over time for atypical antipsychotics in stabilized schizophrenic patients?
Stabilized schizophrenic patients show a wide range of D2 receptor occupancy and plasma concentrations at clinically effective doses, with clinical response maintained at D2RO below 65%.
Answers are grounded in this paper and cite their sources.
May support lower D2 occupancy targets in stabilized schizophrenia; hypothesis-generating and requires randomized confirmation before practice change.
The (123)I-IBZM SPECT measured D(2) receptor occupancy (D(2)RO) in chronically dosed, stabilized schizophrenic patients and its relationship with antipsychotic (AP) pharmacokinetics (PK) over time is still unclear. The aims of this study were: 1) To define the relationship between striatal D(2) receptor occupancy (D( 2)RO) and plasma concentration (C(P)) in stabilized schizophrenic patients on clinically relevant doses using (123)I-IBZM SPECT; 2) To investigate the time course of AP-induced D(2)RO and corresponding C(P). Forty-six schizophrenic patients on their clinically required doses of risperidone, olanzapine, clozapine or quetiapine were included. D( 2)RO and C(P) were measured over time following a sparse-sampling experimental design, and individual PK and D(2)RO-time profiles were estimated using a population approach. Observed striatal D(2)RO and C(P) ranges were 28-75% and 9.4-60.5 ng/mL for risperidone, 22-84% and 8.6-89.5 ng/mL for olanzapine, 5-53% and 41.6-818.2 ng/mL for clozapine and 0-64% and 37.9-719.6 ng/mL for quetiapine. A PK-D(2)RO relationship was found for the four APs. D(2)RO pattern over time was stable for risperidone, olanzapine and clozapine but fluctuating for quetiapine. Stabilized schizophrenic patients show a wide range of both D(2)RO and C(P) at clinically effective doses of the four AP, suggesting that clinical response to these AP may be maintained with D(2)RO below 65%. D(2)RO patterns over time differ between AP. These results should be considered for accurate interpretation of D(2)RO measurements, proper design of studies and optimization of drug regimens for patients on AP treatment.
No takes yet. Share an insight, caveat, or question.
Catafau et al. (2008) conducted an observational in Schizophrenia (n=46). Atypical antipsychotics (risperidone, olanzapine, clozapine, quetiapine) was evaluated on Relationship between striatal D(2) receptor occupancy and plasma concentration over time. Atypical antipsychotics showed a wide range of D2 receptor occupancy at clinically effective doses, suggesting clinical response may be maintained with D2 receptor occupancy below 65%.
Synapse has enriched 10 related papers. Consider them for comparative context: